The Parma step of the Farmindustria roadshow “ Innovation and Value Production - The pharmaceutical industry: a heritage that Italy cannot miss ” was held yesterday at the GSK plant in San Polo di Torrile. Our President Alberto Chiesi, speaking on behalf of the Group, underlined the investments in…
Chiesi is proud to have joined the São Paulo Declaration on Planetary Health, an unprecedented, urgent call to adopt a new holistic approach to the health and well-being of the people and the planet. The Declaration, authored by the Planetary Health Alliance, a global consortium hosted within the…
People, patients, communities, and environment: these are the four cornerstones of the 2021 edition and the strategy of the Chiesi Group, whose commitment has always been to act as a force for good, promoting a mindful and alternative way of doing business Parma (Italy), September 23, 2021 – Global…
By Ugo Di Francesco, CEO After a summer of wildfires and flooding in Europe and further afield, we’re increasingly aware of the devastating impacts of climate change. Yet whilst the immediate effects of higher temperatures and extreme weather events are becoming clear, we are not considering how…
Chiesi Group, the largest international pharmaceutical Group certified B Corp, is among the top 150 Italian companies to be awarded "Leaders in Sustainability 2021". The recognition comes from the survey conducted on approximately 1200 Italian-based corporations by Statista, a leading market…
At Chiesi Diversity & Inclusion (D&I) is part of our culture: as a Benefit company and a certified B Corp, we aim to further enhance an inclusive and open approach in our daily actions, ensuring the well-being of our people, openness to others, a sense of welcome and thus improving individual and…
The Chiesi Group is the number one Italian pharmaceutical company and ranks fourth among Italian companies across all sectors for filing the highest number of patents. The details were published by the European Patent Office (EPO) when the 2020 official data relating to the number of patent…
After the launch of Facebook in 2020 and the continuous growth of the Group’s activities on LinkedIn, Chiesi Group has decided to take a further step in the Social Media world to communicate more directly with its stakeholders. On Twitter (as on Facebook and LinkedIn) several contents will be…
CAR MIEL, Israel, November 27, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based…
You are leaving the Chiesi Corp site to access another Chiesi site. Regulatory constraints and medical practices, as well as the information published on the site you are about to visit, may change from one country to another and may not comply with current Italian legislation on the subject.
You are about to leave our website and access an external site. By continuing, you agree to leave our site.
